Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...

As genetic sequencing technology becomes more accessible and efficient, researchers have made significant strides in understanding the genetic underpinnings of various diseases. This knowledge has led ...

Medicare Part B covers various genetic tests for diagnosing genetic conditions, identifying cancer risks, and predicting medication responses if a doctor deems them medically necessary. The cost of ...

Even though a large proportion of cancer patients carry genetic mutations that make them more susceptible to cancer, only a ...

Medicare generally does not cover genetic screening tests unless they directly affect treatment or lead to a specific diagnosis, with exceptions for specific diseases like cancer. A Medicare-approved ...

Genetic disorders can occur due to mutations in one gene (monogenic), multiple genes (multifactorial inheritance), and mutation in one or more chromosomes. Point mutations are where one nucleotide in ...

Genetic testing, including germline and somatic, is vital for prostate cancer prognosis and personalized treatment strategies. PARP inhibitors, targeting BRCA mutations, are a promising therapy for ...

Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...

Credit: Getty Images In the US, the proportion of men receiving HRR testing peaked at 55.5% in 2020 and decreased to 49.4% in 2022. From 2014-2022, only about 38% of men with metastatic ...